2024
Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective
Yang Z, Guan F, Bronk L, Zhao L. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective. Pharmacology & Therapeutics 2024, 254: 108591. PMID: 38286161, DOI: 10.1016/j.pharmthera.2024.108591.Peer-Reviewed Original ResearchMeSH KeywordsArtificial IntelligenceChemoradiotherapyEsophageal NeoplasmsHumansMultiomicsNeoadjuvant TherapyProteomicsTreatment OutcomeConceptsPathological complete responseNeoadjuvant chemoradiotherapyEsophageal cancerLocally advanced esophageal cancerPathological complete response patientsAdvanced esophageal cancerStandard treatment strategyPredicting treatment responsePredicting nCRT responseMulti-omics dataMulti-omicsComplete responseNeoadjuvant therapyChemoradiation responseNCRT responsePredictive biomarkersSurvival outcomesActive surveillanceTreatment responsePlanned surgeryEC patientsTreatment strategiesMulti-omics approachImproved biomarkersOrgan preservation
2018
Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer
Yang P, Xu T, Gomez DR, Deng W, Wei X, Elhalawani H, Jin H, Guan F, Mirkovic D, Xu Y, Mohan R, Liao Z. Patterns of Local-Regional Failure After Intensity Modulated Radiation Therapy or Passive Scattering Proton Therapy With Concurrent Chemotherapy for Non-Small Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2018, 103: 123-131. PMID: 30165127, DOI: 10.1016/j.ijrobp.2018.08.031.Peer-Reviewed Original ResearchConceptsNon-small cell lung cancerInternal target volumePlanning target volumeCell lung cancerLarge tumorsRegional failureMarginal failureLocal failureLung cancerSmall tumorsCox proportional hazards analysisTarget volumeLocal-regional failureOnly independent predictorOverall survival rateProportional hazards analysisProton therapyComputed tomography simulationPassive Scattering Proton TherapyConcurrent chemotherapyLocoregional failureFavorable survivalIndependent predictorsTumor controlTomography scan
2015
Chemoradiation therapy using cyclopamine-loaded liquid–lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles
You J, Zhao J, Wen X, Wu C, Huang Q, Guan F, Wu R, Liang D, Li C. Chemoradiation therapy using cyclopamine-loaded liquid–lipid nanoparticles and lutetium-177-labeled core-crosslinked polymeric micelles. Journal Of Controlled Release 2015, 202: 40-48. PMID: 25637565, PMCID: PMC4394992, DOI: 10.1016/j.jconrel.2015.01.031.Peer-Reviewed Original ResearchConceptsCombination therapyHigher antitumor cytotoxicityMurine breast cancerMouse xenograft modelCell linesDesirable pharmacokinetic propertiesChemoradiation therapyTumor sizeTumor responseMouse survivalPancreatic cancerAntitumor cytotoxicitySystemic administrationBreast cancerIntravenous injectionPreclinical studiesTumor relapseRadiation therapyXenograft modelIntratumoral injectionAdenocarcinoma modelTumor growthLower clonogenicityCell responsesTherapy